Minimal residual disease (MRD) detection in colorectal cancer (CRC) using a plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay

被引：1
|
作者：
Parikh, A. [1 ]
van Seventer, E. [2 ]
Boland, G. [1 ]
Siravegna, G. [1 ]
Hartwig, A. [3 ]
Jaimovich, A. [4 ]
Raymond, V. M. [5 ]
Talasaz, A. [6 ]
Corcoran, R. B. [7 ]
机构：
[1] Massachusetts Gen Hosp, Hematol Oncol, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA
[3] Guardant Hlth Inc, Res & Dev, Redwood City, CA USA
[4] Guardant Hlth Inc, Bioinformat, Redwood City, CA USA
[5] Guardant Hlth Inc, Med Affairs, Redwood City, CA USA
[6] Guardant Hlth Inc, Redwood City, CA USA
[7] MGH Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.530
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
419P
引用
收藏
页码：S419 / S419
页数：1
相关论文
共 50 条
  • [41] Enhanced detection of molecular residual disease (MRD) by tumor-informed and tumor-agnostic variants in circulating tumor DNA (ctDNA)
    Yan, Xiaoluan
    Li, Zhencong
    Wang, YanYan
    Li, Juan
    Liu, Ming
    Wang, Hongwei
    Jin, Kemin
    Bao, Quan
    Wang, Lijun
    Liu, Wei
    Liu, Lijuan
    Da, Xu
    Hu, Yifan
    Zhang, Yiqun
    Zang, Yuehua
    Pei, Zhihua
    Wang, Dongliang
    Zhou, Qiming
    Xing, Baocai
    Wang, Kun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] PLASMA BASED CELL-FREE CIRCULATING TUMOR DNA (CTDNA) ASSESSMENT FOR NON-INVASIVE DETECTION OF COLORECTAL CANCER (CRC)
    Dean, Jason
    He, Yupeng
    Raymond, Victoria
    Kim, Seung Tae
    Lee, Jeeyun
    Kim, Hee Cheol
    Jaimovich, Ariel
    Talasaz, AmirAli
    GASTROENTEROLOGY, 2020, 158 (06) : S369 - S369
  • [43] Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection
    Xu, Yuyan
    Cai, Jianpeng
    Zhong, Kaihang
    Wen, Yaohong
    Cai, Lei
    He, Guolin
    Liao, Hangyu
    Zhang, Cheng
    Fu, Shunjun
    Chen, Tingting
    Cai, Jinping
    Zhong, Xuefeng
    Chen, Chunzhu
    Huang, Mengli
    Cheng, Yuan
    Pan, Mingxin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS)
    Salawu, Abdulazeez
    Demicco, Elizabeth
    Chung, Peter W. M.
    Feeney, Jordan
    Spickard, Erik
    Rathore, Richa
    Lee, Jasmine
    Wong, Philip
    Malone, Eoghan Ruadh
    Catton, Charles
    Arones, Limore
    Phillips, Madeline J.
    Ferguson, Peter Charles
    Wunder, Jay
    Tin, Tony
    Sethi, Himanshu
    Liu, Minetta C.
    Shultz, David Benjamin
    Razak, Albiruni Ryan Abdul
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Sequencing paired tumor DNA and white blood cells (WBCs) increases sensitivity to track plasma circulating tumor DNA (ctDNA) for detecting minimal residual disease (MRD) in localized colon cancer (CC)
    Tarazona, N.
    Martin-Arana, J.
    Tebar-Martinez, R.
    Lombardi, P.
    Moragon, S.
    Zuniga, S.
    Rentero-Garrido, P.
    Carbonell-Asins, J. A.
    Gambardella, V.
    Huerta, M.
    Rosello, S.
    Martinez-Ciarpaglini, C.
    Alfaro-Cervello, C.
    Moro, D.
    Ferrer-Martinez, A.
    Ponce, M.
    Pena, A.
    Espi, A.
    Roda, D.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S413 - S414
  • [46] The application of circulating tumor DNA for minimal residual disease detection in pancreatic cancer
    Watanabe, Kazunori
    Low, Siew K.
    Chin, Yoon M.
    Chan, Hiu T.
    Nakamura, Toru
    Hirano, Satoshi
    Nakamura, Yusuke
    CANCER SCIENCE, 2022, 113 : 914 - 914
  • [47] Post-operative genomic/epigenomic signatures of circulating tumor DNA and recurrence in colorectal cancer: COSMOS-CRC-01
    Nakamura, Yoshiaki
    Tsukada, Yuichiro
    Murano, Tatsuro
    Matsuhashi, Nobuhisa
    Shiozawa, Manabu
    Kato, Takeshi
    Oki, Eiji
    Goto, Masahiro
    Kagawa, Yoshinori
    Kanazawa, Akiyoshi
    Ohta, Takashi
    Ouchi, Akira
    Bando, Hideaki
    Zuo, Xiaotong
    Parsana, Princy
    Price, Kristin
    Ikematsu, Hiroaki
    Yoshino, Takayuki
    ANNALS OF ONCOLOGY, 2022, 33 : S465 - S466
  • [48] Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer
    Chakrabarti, Sakti
    Mahipal, Amit
    PHARMACOGENOMICS, 2023,
  • [49] Circulating tumor DNA (ctDNA) as a marker of minimal residual disease (MRD) in localized non-small cell lung carcinoma (NSCLC).
    Simon, Nicholas I.
    Davis, Andrew A.
    Mohindra, Nisha Anjali
    Villaflor, Victoria Meucci
    Chae, Young Kwang
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Personalized circulating tumour DNA assay for the detection of minimal residual disease in CRC patients after resection of metastases
    Loupakis, F.
    Derouazi, M.
    Murgioni, S.
    Rizzato, M. D.
    Sharma, S.
    Renner, D.
    Shchegrova, S.
    Sethi, H.
    Zimmermann, B.
    Aleshin, A.
    Schirripa, M.
    Munari, G.
    Dei Tos, A. P.
    Lonardi, S.
    Fassan, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S413 - S413
12345